Redox Reactions of the AdoMet Radical Enzyme Superfamily
Project Number1R01GM120283-01
Contact PI/Project LeaderELLIOTT, SEAN J
Awardee OrganizationBOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
Description
Abstract Text
PROJECT SUMMARY
The AdoMet Radical Enzyme (ARE) superfamily catalyzes a wide array of chemical transformations that span
sulfur-insertion, isomerization, activation of glycyl-radical enzymes, metallo-cofactor biosynthesis,
methylations, oxidations and desaturations. All of these reactions are initiated by similar components: AREs
are marked by an active-site amino acid signature of CX3CX2C (which binds a unique [Fe4S4] cluster) and
structural elements that bind the required co-factor (or co-substrate) S-Adenosyl-methioning (AdoMet). In all
cases, the chemistry of AREs is thought to start with the reductive cleavage of AdoMet by the active site
cluster, resulting in a 5'-dA· radical that is used in the many, many different chemical transformations listed
above. AREs are indeed a superfamily with over 105 distinct members, and recent bioinformatics analyses
have addressed ~50,000 sequences, helping to categorize their reactivity in many distinct biological
roles/pathways involving the synthesis of small molecules, complex natural products, and protein and nucleic
modifications. Further complexity within the ARE superfamily can be found in how many family members have
yet-another redox cofactor, either one or two additional `auxiliary' [Fe4S4] clusters, or cobalamin. Together, the
catalytic and cofactor diversity of the ARE superfamily articulate how very little we understand about the
molecular details that guide the reactivity of AREs, we not only do not understand why different AREs do
different reactions, there is little data on the redox properties of ARE family members, which is essential to
understand how they can achieve the chemistry that they do. We propose to address that knowledge gap. We
have have been recently successful in utilizing the crystallographically-characterized ARE BtrN as a model
system for examining the redox potentials of the AdoMet-binding active site ([Fe4S4]Ado) and the BtrN auxiliary
cluster ([Fe4S4]Aux) using our unique experience in protein film electrochemistry. Here, we propose to (i) use
BtrN as a model system to allow for the systematic assessment of what controls the redox potentials and
proton-coupled nature of the active site, (ii) expand our work on BtrN to other AREs that contain additional FeS
clusters, allowing for the first direct comparison of redox properties between AREs, and (iii) examine the redox
chemistry of cobalamin-containing AREs, in order to further develop protein electrochemistry as a tool for redox
enzymology in the ARE superfamily.
Public Health Relevance Statement
PROJECT NARRATIVE
We propose to study the oxidation/reduction chemistry of enzymes that belong to the AdoMet Radical Enzyme
(ARE) superfamily, which are relevant to human health as AREs are important enzymes in the production of
natural products that can serve as drug molecules. The project will provide insights into the fundamental
processes of ARE function, and provide a new view in how similar enzymes achieve diverse chemistry.
No Sub Projects information available for 1R01GM120283-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01GM120283-01
Patents
No Patents information available for 1R01GM120283-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01GM120283-01
Clinical Studies
No Clinical Studies information available for 1R01GM120283-01
News and More
Related News Releases
No news release information available for 1R01GM120283-01
History
No Historical information available for 1R01GM120283-01
Similar Projects
No Similar Projects information available for 1R01GM120283-01